These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7648357)

  • 21. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
    Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal grammar in the frontotemporal dementia spectrum: evidence of a selective disorder in the corticobasal degeneration syndrome.
    Cotelli M; Borroni B; Manenti R; Ginex V; Calabria M; Moro A; Alberici A; Zanetti M; Zanetti O; Cappa SF; Padovani A
    Neuropsychologia; 2007 Oct; 45(13):3015-23. PubMed ID: 17640688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.
    Buée-Scherrer V; Buée L; Leveugle B; Perl DP; Vermersch P; Hof PR; Delacourte A
    Ann Neurol; 1997 Sep; 42(3):356-9. PubMed ID: 9307257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer disease pathology in amyotrophic lateral sclerosis.
    Hamilton RL; Bowser R
    Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
    Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative neurofilament light and tau immunostaining in frontotemporal dementia.
    Sjögren M; Englund E
    Dement Geriatr Cogn Disord; 2004; 17(4):346-9. PubMed ID: 15178951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
    Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini MG; Padovani A; Di Luca M
    Neurobiol Aging; 2009 Jan; 30(1):34-40. PubMed ID: 17709155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective expression of Ser 199/202 phosphorylated tau in a case of frontotemporal dementia.
    Takamatsu J; Kondo A; Ikegami K; Kimura T; Fujii H; Mitsuyama Y; Hashizume Y
    Dement Geriatr Cogn Disord; 1998; 9(2):82-9. PubMed ID: 9524799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
    Zhukareva V; Sundarraj S; Mann D; Sjogren M; Blenow K; Clark CM; McKeel DW; Goate A; Lippa CF; Vonsattel JP; Growdon JH; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2003 May; 105(5):469-76. PubMed ID: 12677447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
    Flament S; Delacourte A; Verny M; Hauw JJ; Javoy-Agid F
    Acta Neuropathol; 1991; 81(6):591-6. PubMed ID: 1831952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease].
    Flament S; Delacourte A; Hemon B; Defossez A
    C R Acad Sci III; 1989; 308(3):77-82. PubMed ID: 2493316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
    Delacourte A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.
    Vermersch P; Robitaille Y; Bernier L; Wattez A; Gauvreau D; Delacourte A
    Acta Neuropathol; 1994; 87(6):572-7. PubMed ID: 8091949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic and pathological classification of familial frontotemporal dementia.
    Morris HR; Khan MN; Janssen JC; Brown JM; Perez-Tur J; Baker M; Ozansoy M; Hardy J; Hutton M; Wood NW; Lees AJ; Revesz T; Lantos P; Rossor MN
    Arch Neurol; 2001 Nov; 58(11):1813-6. PubMed ID: 11708988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.